Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Seizures]

Toshio Ota1

  • 1Department of Neuropsychiatry, Saitama Medical School.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 4, 2004
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Event-Related Alpha-Band Power Changes During Self-reflection and Working Memory Tasks in Healthy Individuals.

Frontiers in human neuroscience·2021
Same author

Dopamine-induced functional activation of Gα<sub>q</sub> mediated by dopamine D<sub>1</sub>-like receptor in rat cerebral cortical membranes.

Journal of receptor and signal transduction research·2019
Same author

Functional activation of Gα<sub>q/11</sub> protein via α<sub>1</sub> -adrenoceptor in rat cerebral cortical membranes.

Clinical and experimental pharmacology & physiology·2019
Same author

Optimization and pharmacological characterization of receptor-mediated G<sub>i/o</sub> activation in postmortem human prefrontal cortex.

Basic & clinical pharmacology & toxicology·2018
Same author

Chimeric Mice With Humanized Livers Demonstrate Human-Specific Hepatotoxicity Caused by a Therapeutic Antibody Against TRAIL-Receptor 2/Death Receptor 5.

Toxicological sciences : an official journal of the Society of Toxicology·2018
Same author

Preclinical and phase I clinical studies of KW-2450, a dual IGF-1R/IR tyrosine kinase inhibitor, in combination with lapatinib and letrozole.

Therapeutic advances in medical oncology·2018